| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2324062A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 05/25/2011 | EP2324046A2 Tgr5 modulators and methods of use thereof |
| 05/25/2011 | EP2324026A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 05/25/2011 | EP2324025A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 05/25/2011 | EP2324020A2 Piperidine derivatives as jak3 inhibitors |
| 05/25/2011 | EP2324003A1 6-substituted isoflavonoid compounds and uses thereof |
| 05/25/2011 | EP2323689A1 Treatment and/or prevention of peanut induced anaphylaxis |
| 05/25/2011 | EP2323685A2 Agonists of nr2f6 for immunosuppression |
| 05/25/2011 | EP2323679A2 Clip inhibitors and methods of modulating immune function |
| 05/25/2011 | EP2323665A1 Fused heterocyclic compounds useful as kinase modulators |
| 05/25/2011 | EP2323661A1 A3 adenosine receptor allosteric modulators |
| 05/25/2011 | EP1863787B1 Hydogrenated benzo[c]thiophene derivatives as immunomodulators |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1374902B1 Anti-AILIM antibodies for the treatment of Crohn's disease |
| 05/25/2011 | EP1366077B1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | EP0959896B1 Method of producing secreted truncated variants of human thyrotropin receptor |
| 05/25/2011 | CN1772897B Cell factor with several functions |
| 05/25/2011 | CN1285752B Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 05/25/2011 | CN102076845A Compositions for treating an arthritic condition |
| 05/25/2011 | CN102076682A Five-membered ring compound |
| 05/25/2011 | CN102076672A Novel five-membered ring compound |
| 05/25/2011 | CN102076667A Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 05/25/2011 | CN102076661A Antagonists of prostaglandin d2 receptors |
| 05/25/2011 | CN102076335A Paediatric compositions for treating1 multiple sclerosis |
| 05/25/2011 | CN102070726A Method for safely extracting cordyceps sinensis polysaccharide |
| 05/25/2011 | CN102070723A Agaricus bisporus polysaccharide with immunological activity as well as preparation method and application of agaricus bisporus polysaccharide |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070605A Imatinib mesylate polymorph and pharmaceutical composition |
| 05/25/2011 | CN102068634A Externally applied ironing moxibustion clay for human body and manufacturing method thereof |
| 05/25/2011 | CN102068603A Chinese medicament for treating lupus erythematosus |
| 05/25/2011 | CN102068581A Chinese medicinal formula for treating allergic purpura |
| 05/25/2011 | CN102068480A Edible and medicinal compound preparation with effects of heatstroke alleviation and detoxification |
| 05/25/2011 | CN102068447A Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases |
| 05/25/2011 | CN102068444A Ointment for treating skin diseases |
| 05/25/2011 | CN102068434A Application of 4-(cyclohexyl)-aminoquinazoline compounds |
| 05/25/2011 | CN102068432A Externally applied compound composition consisting of tadines and leukotriene antagonist |
| 05/25/2011 | CN102068427A Use of compound |
| 05/25/2011 | CN102068398A Allergy-relieving, anti-inflammatory and anti-irritation skin-care composition, preparation and preparation method thereof |
| 05/25/2011 | CN101690777B Formula of polygonatum chewable tablets and preparation method thereof |
| 05/25/2011 | CN101642546B Chinese patent medicine for eliminating toxin and beautifying faces |
| 05/25/2011 | CN101519451B Recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein gene (sCTLA4-Ig) and pharmaceutical composition thereof |
| 05/25/2011 | CN101507773B Traditional Chinese medicine composite for treating eczema and preparation method thereof |
| 05/25/2011 | CN101485813B Soft capsule for beauty treatment and preparation method thereof |
| 05/25/2011 | CN101480436B Compound Chinese herbal medicine immunopotentiator for grouper |
| 05/25/2011 | CN101480431B Compound Chinese herbal medicine immunopotentiator for egg-shaped pompano |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101444629B Non-injection gene therapy medicine and medicine box thereof |
| 05/25/2011 | CN101401789B Cordyceps sinensis polysaccharide liposome medicament and preparation thereof |
| 05/25/2011 | CN101390925B Composite immunity strengthening agent for fresh water young fish |
| 05/25/2011 | CN101361972B Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 05/25/2011 | CN101259180B Shenshe composition and preparation thereof |
| 05/25/2011 | CN101229291B Chinese traditional medicine composition for treating virus hepatitis by immunoregulation |
| 05/25/2011 | CN101199681B Oral administration Chinese medicine for treating chronicity eczema |
| 05/25/2011 | CN101182448B Method for preparing non-toxic globefish fin wine |
| 05/25/2011 | CN101085349B Vesicle guiding immunocyte and application of the same in preparing antineoplastic medicine |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947697 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d] pyrazolo[1,5-a]pyrimidine methanesulfonate as a CRF antagonist |
| 05/24/2011 | US7947693 5,7-disubstituted thiazolo[4,5-D]pyrimidines as chemokine inhibitors |
| 05/24/2011 | US7947668 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 05/24/2011 | US7947498 Embryonic stem cells and neural progenitor cells derived therefrom |
| 05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
| 05/24/2011 | US7947312 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 05/24/2011 | US7947290 Protease-resistant modified SEB and vaccine containing the same |
| 05/24/2011 | US7947273 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma |
| 05/24/2011 | US7947272 Using mixture comprising inhibitors of CD4, CD25 and interleukin induction as tool in reducing immune response to tissue graft; preventing transplant rejection |
| 05/24/2011 | CA2493026C Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines |
| 05/24/2011 | CA2491701C Fredericamycin derivatives as drugs for tumor treatment |
| 05/24/2011 | CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 05/24/2011 | CA2467552C Nicotin-or isonicotin benzothiazole derivatives |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2440596C Soluble heterodimeric cytokine receptor |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 05/24/2011 | CA2229631C Gene therapy using ovine adenoviral vectors |
| 05/24/2011 | CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 05/24/2011 | CA2133409C Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 05/19/2011 | WO2011060260A2 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
| 05/19/2011 | WO2011059110A1 Therapeutic agent for psoriasis or atopic dermatitis |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058400A1 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses |
| 05/19/2011 | WO2011058321A1 Conjugate molecule |
| 05/19/2011 | WO2011058149A1 Tricyclic pyrazol amine derivatives |
| 05/19/2011 | WO2011058113A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058110A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058109A1 Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors |
| 05/19/2011 | WO2011057340A1 Process for plant bioactive enrichment |
| 05/19/2011 | WO2011009047A3 Il-1ra-polymer conjugates |
| 05/19/2011 | WO2011007961A3 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitpoes |
| 05/19/2011 | WO2011007350A3 Use of nle proteins and tissue - targeted delivery system thereof for the treatment of imune-related disorders |
| 05/19/2011 | WO2011003018A3 Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof |
| 05/19/2011 | WO2010147387A3 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides as active ingredients |
| 05/19/2011 | WO2010144602A3 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use |
| 05/19/2011 | WO2010144140A3 Egfr and par2 regulation of intestinal permeability |
| 05/19/2011 | US20110118352 Oat extracts: refining, compositions and methods of use |
| 05/19/2011 | US20110118341 Long term disease modification using immunostimulatory oligonucleotides |
| 05/19/2011 | US20110118324 Method and composition for treating multiple sclerosis (variants) |